BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8344785)

  • 1. Detection of melanocytes from uveal melanoma in peripheral blood using the polymerase chain reaction.
    Tobal K; Sherman LS; Foss AJ; Lightman SL
    Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2622-5. PubMed ID: 8344785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of tyrosinase mRNA from the blood of melanoma patients.
    Stevens GL; Scheer WD; Levine EA
    Cancer Epidemiol Biomarkers Prev; 1996 Apr; 5(4):293-6. PubMed ID: 8722221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating tumor cells as prognostic factor for distant metastases and survival in patients with primary uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Scheibenbogen C; Thiel E; Foerster MH; Keilholz U
    Clin Cancer Res; 2007 Feb; 13(4):1171-8. PubMed ID: 17317826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of the tyrosinase mRNA probe to detect circulating melanocytes with reverse transcription and polymerase chain reaction.
    Carrillo E; Marchal JA; Prados J; Melguizo C; Vélez C; Arena N; Alvarez L; Serrano S; Aránega A
    Cell Mol Biol (Noisy-le-grand); 1998 Dec; 44(8):1247-52. PubMed ID: 9874512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of tyrosinase mRNA in the peripheral blood of stage I melanoma patients is not of clinical relevance in predicting metastasis risk and survival.
    Aubin F; Chtourou M; Teyssier JR; Laubriet A; Mougin CH; Blanc D; Humbert P
    Melanoma Res; 2000 Apr; 10(2):113-8. PubMed ID: 10803711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Detection of circulating neoplastic cells by reverse transcriptase and polymerase chain reaction in melanoma].
    Tessier MH; Denis MG; Lustenberger P; Dreno B
    Ann Dermatol Venereol; 1997; 124(9):607-11. PubMed ID: 9739921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tyrosinase mRNA levels in the blood of uveal melanoma patients: correlation with the number of circulating tumor cells and tumor progression.
    Pinzani P; Mazzini C; Salvianti F; Massi D; Grifoni R; Paoletti C; Ucci F; Molinara E; Orlando C; Pazzagli M; Neri B
    Melanoma Res; 2010 Aug; 20(4):303-10. PubMed ID: 20442676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction for tyrosinase and MART-1 after mononuclear cell collection with cell preparation tubes: a comparison with the whole blood guanidinium isothiocyanate RNA isolation method.
    de Vries TJ; Fourkour A; Punt CJ; Ruiter DJ; van Muijen GN
    Melanoma Res; 2000 Apr; 10(2):119-26. PubMed ID: 10803712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A polymerase chain reaction-based semiquantitative assessment of malignant melanoma cells in peripheral blood.
    Brossart P; Schmier JW; Krüger S; Willhauck M; Scheibenbogen C; Möhler T; Keilholz U
    Cancer Res; 1995 Sep; 55(18):4065-8. PubMed ID: 7664281
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic relevance of circulating tumor cells in metastatic uveal melanoma.
    Schuster R; Bechrakis NE; Stroux A; Busse A; Schmittel A; Thiel E; Foerster MH; Keilholz U
    Oncology; 2011; 80(1-2):57-62. PubMed ID: 21625180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular test for the detection of tumor cells in blood and sentinel nodes of melanoma patients.
    Van der Velde-Zimmermann D; Roijers JF; Bouwens-Rombouts A; De Weger RA; De Graaf PW; Tilanus MG; Van den Tweel JG
    Am J Pathol; 1996 Sep; 149(3):759-64. PubMed ID: 8780380
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of circulating melanoma cells in peripheral blood of patients with primary uveal melanoma.
    Ulmer A; Beutel J; Süsskind D; Hilgers RD; Ziemssen F; Lüke M; Röcken M; Rohrbach M; Fierlbeck G; Bartz-Schmidt KU; Grisanti S
    Clin Cancer Res; 2008 Jul; 14(14):4469-74. PubMed ID: 18628461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of melanoma cells in peripheral blood by reverse transcription-polymerase chain reaction.
    Foss AJ; Guille MJ; Occleston NL; Hykin PG; Hungerford JL; Lightman S
    Br J Cancer; 1995 Jul; 72(1):155-9. PubMed ID: 7599046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of circulating melanoma cells detected by reverse transcriptase-polymerase chain reaction for tyrosinase mRNA in patients with melanoma.
    Visús C; Andres R; Mayordomo JI; Martinez-Lorenzo MJ; Murillo L; Sáez-Gutiérrez B; Diestre C; Marcos I; Astier P; Godino J; Carapeto-Marquez de Prado FJ; Larrad L; Tres A
    Melanoma Res; 2007 Apr; 17(2):83-9. PubMed ID: 17496783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymerase chain reaction detection of circulating melanocytes as a prognostic marker in patients with melanoma.
    Battayani Z; Grob JJ; Xerri L; Noe C; Zarour H; Houvaeneghel G; Delpero JR; Birmbaum D; Hassoun J; Bonerandi JJ
    Arch Dermatol; 1995 Apr; 131(4):443-7. PubMed ID: 7726587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of the RT-PCR technique to detect melanoma cells in peripheral blood.
    Suárez A; Fra J; Alonso R; Sánchez R; Lacave AJ; Gutiérrez C
    Anticancer Res; 2002; 22(2B):1091-5. PubMed ID: 12168906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathways mediating liver metastasis in patients with uveal melanoma.
    Bakalian S; Marshall JC; Logan P; Faingold D; Maloney S; Di Cesare S; Martins C; Fernandes BF; Burnier MN
    Clin Cancer Res; 2008 Feb; 14(4):951-6. PubMed ID: 18281525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes.
    Calogero A; Timmer-Bosscha H; Schraffordt Koops H; Tiebosch AT; Mulder NH; Hospers GA
    Br J Cancer; 2000 Jul; 83(2):184-7. PubMed ID: 10901368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reproducibility of detection of tyrosinase and MART-1 transcripts in the peripheral blood of melanoma patients: a quality control study using real-time quantitative RT-PCR.
    de Vries TJ; Fourkour A; Punt CJ; van de Locht LT; Wobbes T; van den Bosch S; de Rooij MJ; Mensink EJ; Ruiter DJ; van Muijen GN
    Br J Cancer; 1999 May; 80(5-6):883-91. PubMed ID: 10360670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of ocular and metastatic uveal melanoma in an animal model.
    Blanco PL; Marshall JC; Antecka E; Callejo SA; Souza Filho JP; Saraiva V; Burnier MN
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4376-82. PubMed ID: 16303923
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.